ADV-P8

N/A

Report date: 2023/02/04 20:21:26

NME

Base Information

Drug NameADV-P8

Drug Alias NameADV P8

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsDepressive Disorder, Major

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAdvancell

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAdvancell

Active IndicationsN/A

Inactive IndicationsDepressive Disorder, Major

ATC CodeN/A